Cell Cycle

Cell cycle is the entire process of cell division from the completion of one division to the end of the next division and is divided into two phases: interphase and division. Life is a continuous process passed from generation to generation and is therefore a process of constant renewal and starting from scratch. Thus, it is a process of constant renewal and starting from scratch. The life of a cell begins with the division of its parent cell and ends with the formation of its daughter cells, or the death of the cell itself. Usually, the formation of daughter cells is considered to mark the end of cell division. The cell cycle is the process from the formation of daughter cells at one cell division to the formation of daughter cells at the next cell division. During this process, the genetic material of the cell is copied and distributed equally to the two daughter cells.

Cat. No.	Product name
BP13309	LDC4297
BP13309	LDC4297 is a potent and selective CDK7 inhibitor.
BP13310	LDN-192960
BP13310	LDN-192960 is a potent inhibitor of Haspin and DYRK2 (IC50s: 10 nM and 48 nM).
BP13311	LDN-91946
BP13311	LDN-91946 is an effective and selective inhibitor of ubiquitin C-terminal hydrolase-L1 (UCH-L1) (Ki = 2.8 μM).
BP13312	Lerociclib
BP13312	Lerociclib (G1T38) is a potent and selective inhibitor of CDK4/6, with IC50s of 2nM, 1 nM for CDK6/CyclinD3 and CDK4/CyclinD1, respectively.
BP13313	Lerociclib dihydrochloride
BP13313	Lerociclib dihydrochloride is a potent and selective inhibitor of CDK4/CDK6, with IC50s of 2 nM and 1 nM for CDK6/CyclinD3 and CDK4/CyclinD1, respectively.
BP13314	Folinic acid calcium
BP13314	Leucovorin calcium is the active metabolite of folic acid. Leucovorin is used principally as an antidote to folic acid antagonists.
BP13315	Levomefolate calcium
BP13315	Levomefolate calcium is an artificial form of folate. It is a coenzymated form of folic acid and a more bioavailable alternative in dietary supplements.
BP13316	Licorisoflavan A
BP13316	Licorisoflavan A shows weak scavenging activity against superoxide anion radical, it and licoricidin have potential for the development of novel host-modulating strategies for the treatment of cytokine and/or MMP-mediated disorders such as periodontitis.Licorisoflavan A has bactericidal effects on S. mutans UA159 at the concentration of ≥4 g/ml, it can be useful in developing oral hygiene products, such as gargling solutions and dentifrices for preventing dental caries.
BP13317	LIMK-IN-22j
BP13317	LIMK-IN-22j is an effective and selective inhibitor of LIMK.
BP13318	Branaplam
BP13318	LMI070 (NVS-SM1) is a highly potent, selective and orally active small molecule SMN2 splicing modulator.
BP13319	Longdaysin
BP13319	Longdaysin is an inhibitor of CK1α and CK1δ (IC50s: 5.6/8.8 μM). It also can inhibit ERK2 (IC50: 52 μM).
BP13320	Lusianthridin
BP13320	Lusianthridin is a natural product from Dendrobium venustum. Lusianthridin exhibits anti-migratory property at nontoxic concentrations. Lusianthridin enhances c-Myc degradation through the inhibition of Src-STAT3 signaling.
BP13321	LX7101
BP13321	LX7101 is an effective inhibitor of LIMK and ROCK2 (IC50: 24, 1.6, and 10 nM for LIMK1, LIMK2, and ROCK2, respectively). It also inhibits PKA (IC50 <1 nM).
BP13322	LY 222306
BP13322	LY 222306 is a glycinamide ribonucleotide formyltransferase (GARFT) inhibitor with a Ki of 0.77 nM.
BP13323	LY 345899
BP13323	LY 345899 is a Folate analog and is a methylenetetrahydrofolate dehydrogenase and MTHFD2 inhibitor (IC50: 96 nM and 663 nM, respectively and a Ki: 18 nM for MTHFD1).
BP13324	LY2334737
BP13324	LY2334737 is an orally available prodrug of gemcitabine with antineoplastic activity.
BP13325	Abemaciclib methanesulfonate
BP13325	LY2835219 is a specific and effective inhibitor of CDK4(IC50=2 nM) and CDK6(IC50=10 nM).
BP13326	Abemaciclib
BP13326	LY2835219 is an effective and specific CDK4/6 inhibitor (IC50: 2/10 nM).
BP13327	LY2880070
BP13327	LY2880070 is a new checkpoint kinase 1 (CHK1) inhibitor for cancer therapy.
BP13328	LY3143921 hydrate
BP13328	LY3143921 hydrate is an orally administered ATP-competitive CDC7 inhibitor.